» Articles » PMID: 22891346

An Image-based Screen Identifies a Small Molecule Regulator of Megakaryopoiesis

Overview
Specialty Science
Date 2012 Aug 15
PMID 22891346
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Molecules that control the lineage commitment of hematopoietic stem cells (HSCs) may allow the expansion of enriched progenitor populations for both research and therapeutic uses. In an effort to better understand and control the differentiation of HSCs to megakaryocytes, we carried out an image-based screen of a library of 50,000 heterocycles using primary human CD34(+) cells. A class of naphthyridinone derivatives was identified that induces the differentiation of common myeloid progenitors (CMP) to megakaryocytes. Kinase profiling and subsequent functional assays revealed that these compounds act through inhibition of platelet-derived growth factor receptor (PDGFR) signaling in CMPs. Such molecules may ultimately have clinical utility in the treatment of thrombocytopenia.

Citing Articles

RUNX1-deficient human megakaryocytes demonstrate thrombopoietic and platelet half-life and functional defects.

Lee K, Ahn H, Estevez B, Poncz M Blood. 2022; 141(3):260-270.

PMID: 36219879 PMC: 9936297. DOI: 10.1182/blood.2022017561.


The GABA receptor GABRR1 is expressed on and functional in hematopoietic stem cells and megakaryocyte progenitors.

Zhu F, Feng M, Sinha R, Murphy M, Luo F, Kao K Proc Natl Acad Sci U S A. 2019; 116(37):18416-18422.

PMID: 31451629 PMC: 6744911. DOI: 10.1073/pnas.1906251116.


A Fully Automated High-Throughput Flow Cytometry Screening System Enabling Phenotypic Drug Discovery.

Joslin J, Gilligan J, Anderson P, Garcia C, Sharif O, Hampton J SLAS Discov. 2018; 23(7):697-707.

PMID: 29843542 PMC: 6055113. DOI: 10.1177/2472555218773086.


Novel TPO receptor agonist TA-316 contributes to platelet biogenesis from human iPS cells.

Aihara A, Koike T, Abe N, Nakamura S, Sawaguchi A, Nakamura T Blood Adv. 2018; 1(7):468-476.

PMID: 29296963 PMC: 5738977. DOI: 10.1182/bloodadvances.2016000844.


Human is a key target of RUNX1 in megakaryocytic differentiation.

Li Y, Jin C, Bai H, Gao Y, Sun S, Chen L Blood. 2017; 131(2):191-201.

PMID: 29101237 PMC: 5757696. DOI: 10.1182/blood-2017-04-780379.


References
1.
Li X, Eriksson U . Novel PDGF family members: PDGF-C and PDGF-D. Cytokine Growth Factor Rev. 2003; 14(2):91-8. DOI: 10.1016/s1359-6101(02)00090-4. View

2.
Lyssiotis C, Lairson L, Boitano A, Wurdak H, Zhu S, Schultz P . Chemical control of stem cell fate and developmental potential. Angew Chem Int Ed Engl. 2010; 50(1):200-42. DOI: 10.1002/anie.201004284. View

3.
Elliott S . Erythropoiesis-stimulating agents. Cancer Treat Res. 2010; 157:55-74. DOI: 10.1007/978-1-4419-7073-2_4. View

4.
Szalai G, LaRue A, Watson D . Molecular mechanisms of megakaryopoiesis. Cell Mol Life Sci. 2006; 63(21):2460-76. PMC: 11136211. DOI: 10.1007/s00018-006-6190-8. View

5.
Fujiki H, Kimura T, Minamiguchi H, Harada S, Wang J, Nakao M . Role of human interleukin-9 as a megakaryocyte potentiator in culture. Exp Hematol. 2002; 30(12):1373-80. DOI: 10.1016/s0301-472x(02)00966-9. View